Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 10/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.43 |
| ▸ | SLC5A1 | P13866 | 5/20 | 0.43 |
| ▸ | SELL | P14151 | 1/20 | 0.41 |
| ▸ | SELP | P16109 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22314229 | 0.85 | SLC5A2 (0.59) | SLC5A2SLC5A1SELLSELPACHE | |
| SCHEMBL26192723 | 0.85 | SLC5A2 (0.59) | SLC5A2SLC5A1SELLSELPACHE | |
| SCHEMBL22314236 | 0.85 | SLC5A2 (0.59) | SLC5A2SLC5A1SELLSELPACHE | |
| SCHEMBL22342688 | 0.72 | SLC5A2 (0.39) | SLC5A2CA12CA1CA7CA9 | |
| SCHEMBL22314228 | 0.72 | SLC5A2 (0.39) | SLC5A2CA12CA1CA7CA9 | |
| SCHEMBL20506685 | 0.72 | SLC5A2 (0.39) | SLC5A2CA12CA1CA7CA9 | |
| SCHEMBL27260200 | 0.72 | SLC5A2 (0.39) | SLC5A2CA12CA1CA7CA9 | |
| SCHEMBL22314230 | 0.72 | SLC5A2 (0.39) | SLC5A2CA12CA1CA7CA9 | |
| SCHEMBL22570833 | 0.72 | SLC5A2 (0.39) | SLC5A2CA12CA1CA7CA9 | |
| SCHEMBL19673038 | 0.71 | KDM4E (0.55) | SLC5A2CA12CA1CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023122750-A1 | CANCER COMBINATION THERAPY WITH IL-2 CONJUGATES AND CETUXIMAB | Synthorx, Inc. (US) | 2023-06-29 | — | — | WO | disclosed |